Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Ankur K. Patel"'
Autor:
Thomas M. Kaffenberger, Ankur K. Patel, Lingyun Lyu, Jinhong Li, Tamara Wasserman‐Wincko, Dan P. Zandberg, David A. Clump, Jonas T. Johnson, Marci L. Nilsen
Publikováno v:
Laryngoscope Investigative Otolaryngology, Vol 6, Iss 5, Pp 983-990 (2021)
Abstract Objectives Oropharyngeal squamous cell carcinoma (OPSCC) treatment results in impaired swallowing and quality of life (QOL). We analyzed a cross‐section of advanced stage OPSCC patients treated with multimodal therapies at our Survivorship
Externí odkaz:
https://doaj.org/article/7d3e4479f0ba4dedb79d3aa3c608108c
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
IntroductionImaging is integral part of cervical cancer management. Currently, MRI is used for staging, follow up and image guided adaptive brachytherapy. The ongoing IQ-EMBRACE sub-study is evaluating the use of MRI for functional imaging to aid in
Externí odkaz:
https://doaj.org/article/1de933243da44f608376fc0c34b2da7c
Autor:
Adrianna E. Mojica‐Márquez, Joshua L. Rodríguez‐López, Ankur K. Patel, Diane C. Ling, Malolan S. Rajagopalan, Sushil Beriwal
Publikováno v:
Cancer Medicine, Vol 9, Iss 16, Pp 5781-5787 (2020)
Abstract Background The TEACHH and Chow models were developed to predict life expectancy (LE) in patients evaluated for palliative radiotherapy (PRT). We sought to validate the TEACHH and Chow models in patients who died within 90 days of PRT consult
Externí odkaz:
https://doaj.org/article/082adc474d1f40318567c8196bbe7b3c
Publikováno v:
Brachytherapy. 21:79-84
To evaluate our institutional outcomes utilizing Cs-131 prostate brachytherapy (PB) for the intermediate-risk (IR) group of prostate cancer patients.We reviewed a prospectively collected database of men treated with Cs-131 PB between 2006 and 2019. P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c1e1e05b73249c43d41c3cef572193e
https://doi.org/10.1016/j.brachy.2021.08.008
https://doi.org/10.1016/j.brachy.2021.08.008
Publikováno v:
Clinical Lung Cancer. 22:e808-e816
Background Conflicting data exists regarding the benefit of prophylactic cranial irradiation (PCI) in patients with extensive-stage small-cell lung cancer (ES-SCLC). We sought to retrospectively review outcomes of patients within our network with ES-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6deab4ae76def5823284d527b6146356
https://doi.org/10.1016/j.cllc.2021.03.009
https://doi.org/10.1016/j.cllc.2021.03.009
Autor:
Ryan P. Smith, Ronald M. Benoit, Joshua L. Rodríguez-López, Michael D. Schad, Ankur K. Patel, Sushil Beriwal, Christopher J. Houser, Zachary D. Horne
Publikováno v:
Brachytherapy. 20:859-865
Baseline intraprostatic calcification (IC) has been shown to be associated with a higher rate of biochemical recurrence (BCR) in men treated with iodine-125 prostate brachytherapy (PB). We evaluated this association in a cohort of men treated with ce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6defe6562a4b7d1529889665116743a7
https://doi.org/10.1016/j.brachy.2021.03.013
https://doi.org/10.1016/j.brachy.2021.03.013
Autor:
Vikram C. Gorantla, Ankur K. Patel, Atilla Soran, Priscilla F. McAuliffe, Adam H. Richman, Emilia J Diego, Jennifer G. Steiman, Sushil Beriwal, Adam Brufsky, Ronald Johnson, Joanna S Lee
Publikováno v:
Cancer Research. 81:PD4-08
Purpose/ObjectivesGene profiling Recurrence Score (RS) assays are commonly used to identify patients with hormone receptor (HR) positive, HER-2 negative invasive breast cancer (IBC) who might benefit from systemic chemotherapy. More recently, the 21-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::94fd961cd0f3a44dcc3d96500f362aee
https://doi.org/10.1158/1538-7445.sabcs20-pd4-08
https://doi.org/10.1158/1538-7445.sabcs20-pd4-08
Autor:
Ankur K. Patel, Sushil Beriwal, John A. Vargo, Scott Glaser, Goundappa K. Balasubramani, Joshua L. Rodríguez-López
Publikováno v:
Leukemia & Lymphoma. 62:538-548
The role of consolidative radiotherapy (RT) is less substantiated in uncommon peripheral T-cell lymphomas (PTCLs). Anaplastic lymphoma kinase (ALK) mutation sub-categorizes PTCLs, with ALK (+) having a distinctly favorable prognosis. We aimed to use
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d2c6bb9168eb15155d7370833ecb0e3
https://doi.org/10.1080/10428194.2020.1842398
https://doi.org/10.1080/10428194.2020.1842398
Autor:
Ankur K. Patel, Steven A. Burton, Dwight E. Heron, Adam C. Olson, Nathan Bahary, Joshua L. Rodríguez-López, Amer H. Zureikat
Publikováno v:
Advances in Radiation Oncology
Purpose There is no consensus on treatment volumes for adjuvant stereotactic body radiation therapy (SBRT) for pancreatic cancer. Herein, we report patterns of failure after pancreatic SBRT for close/positive margins, which may inform target volume d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9800c2a893ccee4ea13454af0260d56f
https://doi.org/10.1016/j.adro.2020.08.006
https://doi.org/10.1016/j.adro.2020.08.006
Autor:
P. Sukumvanich, Jamie L. Lesnock, Robert P. Edwards, Ankur K. Patel, Madeleine Courtney-Brooks, Rohit Bhargava, B.C. Orr, D.C. Ling, Michelle M. Boisen, Jessica Berger, John T. Comerci, Alexander B. Olawaiye, Sarah Taylor, John A. Vargo, Phillip M. Pifer, Sushil Beriwal
Publikováno v:
Gynecologic Oncology. 159:23-29
Objectives A pooled analysis of PORTEC-1 & 2 identified substantial lymphovascular space invasion (LVSI) in 4.8% of patients, which predicted for pelvic recurrence, distant metastasis, and overall survival. Our institution implemented the PORTEC thre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77f49ef9d95448a2af74ac95cd938dea
https://doi.org/10.1016/j.ygyno.2020.07.024
https://doi.org/10.1016/j.ygyno.2020.07.024